Background. Infections are risk factors for venous thromboembolism (VTE), especially if severe and acute. The role of chronic infections such as active tuberculosis is ill defined, although several case reports and small series have suggested an association between tuberculosis and VTE.
Venous thromboembolism (VTE), that is, deep vein thrombosis (DVT) and/or pulmonary embolism (PE), is frequent among hospitalized and nonhospitalized individuals and carries significant morbidity and mortality [1, 2] . PE is the third most common cause of death from cardiovascular diseases after heart attack and stroke [1] .
Many risk factors are known for VTE [3, 4] . Among these, infections are considered classic risk factors requiring thromboprophylaxis [5] , especially if severe and acute. Rogers et al found that 52% of hospitalized VTE cases were preceded by an infection [6] , and Schmidt et al retrospectively observed a 3-to 12-fold increase of VTE risk after various acute infections [7] . The case for chronic infections is less clear, but chronic inflammation associated with such conditions may also favor VTE. Tuberculosis, one of the most prevalent severe infections worldwide, most usually presents as a chronic disease. Previous studies have explored the association between tuberculosis and VTE, but relied upon case reports or small case series, or have been conducted in countries with both poor public sanitation and high tuberculosis incidence [8] [9] [10] [11] . The methodology and the studied populations do not therefore allow any extrapolation to countries with better levels of public sanitation.
The aim of this study was to clarify the association between tuberculosis and VTE in a multiethnic population with a generally good level of public sanitation and low incidence of tuberculosis, by using data from the United States.
METHODS

Data Source
We conducted a retrospective study using data from the Premier Perspective database, the largest hospital clinical and financial database in the United States. It features >45 million discharges from a representative group of hospitals managed by Premier Healthcare Alliance, including 425 short-term stay hospitals throughout the United States. The Premier Perspective database contains billing details for all admissions (hospitalizations and outpatient consultations), such as patients' coded medical history, admission and discharge diagnosis, demographics, source of admission, admission and discharge dates, physicians' specialties, and basic hospital characteristics. It uses the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes. In addition, procedure codes, drugs, and laboratory tests are recorded. We studied the data for the year 2006, representing 33 048 852 inpatient and outpatient admissions.
Study Population
We selected male and female adult patients (aged ≥18 years) discharged between 1 January 2006 and 31 December 2006. We excluded patients with chronic curative anticoagulation for reasons other than VTE (chronic therapy was assumed when patients were prescribed curative anticoagulation during day 1, 2, or 3 of the hospital stay), with chronic thrombosis, superficial vein thrombosis, or DVT at any site except the lower limbs (upper limbs, hepatic veins, portal vein, cerebral veins, etc). Thrombosis of vena cava and iliac veins were classified as lower limb DVT. Curative anticoagulation was defined as a daily cumulative dose of heparin ≥15 000 IU, a vitamin K antagonist, or a curative dose of low-molecular-weight heparin. Preventive anticoagulation was defined as a daily cumulative dose of heparin inferior to 15 000 IU or a preventive dose of lowmolecular-weight heparin (Supplementary Data 1) .
The remaining patients were divided into 2 groups, one composed of all patients with VTE, and the second group including all the other patients.
ICD-9-CM Codes
All the diagnoses were identified according to the ICD- 4 , and 671.9. Tuberculosis was identified using codes 010-018 and 647.3, and was divided into pulmonary tuberculosis and extrapulmonary tuberculosis. Because 647.3 is the code for "Tuberculosis complicating pregnancy, childbirth or the puerperium" and does not specify whether the tuberculosis was pulmonary or extrapulmonary, the 19 concerned tuberculosis cases were not classified into pulmonary or extrapulmonary. All the codes were assumed to describe active tuberculosis, as the specific code "Past history of tuberculosis" (V12.01) should include all inactive tuberculosis.
Outcomes
The primary outcome was a combination of tuberculosis and VTE in the same hospital admission. The following potential confounders were analyzed (Supplementary Data 2): age, sex, ethnic group, hospital status (inpatient/outpatient), and the classic risk factors for VTE: malignant neoplasia, personal or familial history of VTE, autoimmune disease, heart failure, respiratory failure, varicose veins, obesity, nephrotic syndrome, nutritional deficiency, thrombophilia, myocardial infarction, severe infection, pregnancy, inflammatory bowel disease, traumatism, dehydration, and estrogen-based medication (contraception or hormone replacement therapy). All the diagnoses could be primary or secondary, or on admission. Patients were classified into 4 groups depending on the number of recorded VTE risk factors (0, 1, 2, or ≥3). Nutritional deficiency was analyzed separately because it is frequent in patients with active tuberculosis and could therefore be considered to be a confounding bias. The results were also adjusted on the heparinbased prophylaxis.
The secondary outcomes were (1) a description of the prevalence of tuberculosis and VTE, (2) an analysis of mortality and ethnic differences considering both tuberculosis and VTE, and (3) an analysis of subclasses of VTE and tuberculosis to determine if there was a predominant link between the pulmonary forms of tuberculosis and VTE or between the "extrapulmonary" forms of these 2 diseases, based on the physiopathology of PE.
Statistical Analysis
Statistical analyses were performed using Stata software (version 12.0; StataCorp, College Station, Texas). Categorical variables were expressed as frequency with the binomial exact 95% confidence interval (CI) if necessary. Continuous variables were expressed as median and 5th-95th percentiles. Twosided P values of <.05 were considered statistically significant.
We performed univariate and multivariate logistic regression to estimate the nonadjusted and adjusted odds ratios (ORs) and corresponding 95% CIs associated with each risk factor for VTE. The variables that were not significant risk factors in univariate analysis were not included in the multivariate model. The performance of the model is presented with area under the curve analysis. The secondary analyses were performed using uncorrected χ 2 tests or univariate and multivariate analysis.
RESULTS
Descriptive Statistics
A total of 27 659 947 hospital admissions were retained after screening for eligibility, of which 199 552 were in the VTE group and 27 460 395 in the group without VTE ( Figure 1 ). Median age was 53 years (5th-95th percentiles, 22-84 years).
The female-to-male ratio was 1.77:1. Racial and other general characteristics of the population are shown in Table 1 .
In our population, the prevalence (with 95% CIs) of VTE, PE, and DVT was 0.72% (.72%-.72%), 0.27% (.26%-.27%), and 0.51% (.51%-.52%), respectively. Of the 199 552 VTE cases, 125 956 (63%) were DVT, and 73 596 (37%) were PE (with or without DVT). The prevalence of active tuberculosis was 0.01% (95% CI, .01%-.01%). Of the 3485 cases of active tuberculosis, 2982 (85.6%) were pulmonary and 484 (13.9%) were extrapulmonary. In 45 (1.3%) cases of tuberculosis, both the lungs and other sites were affected. The site was not specified in 19 (0.5%) cases of active tuberculosis in pregnant women.
From the total of 199 552 VTE patients, 72 (0.04%) were diagnosed with coexisting tuberculosis (33 males, 39 females; median age, 59.5 years [5th-95th percentiles, 23-88 years]). Fifty-nine patients had pulmonary tuberculosis, 13 had extrapulmonary tuberculosis, and 2 had both; 33 had PE and 39 had DVT. The prevalence (with 95% CIs) of PE and VTE was 0.95% (.65%-1.33%) and 2.07% (1.62%-2.59%), respectively, among the patients with active tuberculosis and 0.27% (.26%-.27%) and 0.72% (.72%-.72%), respectively, among the patients without active tuberculosis.
Univariate Analysis
Patients with active tuberculosis had a greater risk of VTE than those without (OR = 2.90 [95% CI, 2.30-3.67]), close to the risk observed for patients having 1 VTE risk factor (OR = 2.16 [95% CI, 2.14-2.18]). All classic VTE risk factors were associated with VTE (Table 2 , Supplementary Data 3). As expected, the risk rose as the number of classic VTE risk factors increased.
Men were at a slightly higher risk than women (OR = 1.35 [95% CI, 1.34-1.36]), and the risk of VTE increased almost linearly by year of age (OR = 1.03 [95% CI, 1.03-1.03]). Heparinbased prophylaxis was found to be statistically significantly associated with VTE, probably reflecting an indication bias.
Multivariate Analysis
Tuberculosis was found to be associated with VTE (OR = 1.55 [95% CI, 1.23-1.97]). All the other associations found in univariate analysis were also significant in multivariate analysis, although with a lower OR ( Table 2 ). The proportion of patients 
Mortality Analysis
In-hospital mortality of patients with both active tuberculosis and VTE (11/ Data 4) . There was no survival difference between pulmonary and extrapulmonary tuberculosis.
Analysis of Subclasses of VTE and Tuberculosis
No predominant link was observed between the pulmonary forms of the 2 diseases ( pulmonary tuberculosis and PE), or between the extrapulmonary forms of these 2 diseases (extrapulmonary tuberculosis and DVT); all forms of VTE could be associated with all forms of tuberculosis (data not shown).
Analysis of Ethnic Differences
In univariate analysis, white patients had the highest risk of VTE, with black patients second (Table 2) . However, in multivariate analysis, black patients were the most at risk. Black patients were younger (median age, 45 years [5th-95th percentiles, 20-79 years] vs 56 years [22-85 years] ) and less often male (32.34% vs 37.06%) than white patients. This difference may be explained by the fact that in univariate analysis, whites are at higher risk because they are older and more often male, but when adjusted for these 2 classic risk factors [15] [16] [17] , blacks appear to be at higher risk, as described in the literature [18, 19] .
The prevalence of tuberculosis was highest in people of Asian or Pacific Islander origin (0.08%), followed by black and Hispanic (0.03%), American Indian (0.02%), and finally white patients (0.01%).
DISCUSSION
This analysis of data extracted from a very large database, and adjusted for many classic VTE risk factors, suggests that tuberculosis is an independent risk factor for VTE. We found that adults with tuberculosis have a greater risk of VTE than those without tuberculosis (OR = 1.55 [95% CI, 1.23-1.97]), close to neoplasia with an OR of 1.62 in the MEDENOX study [3] . Such an association was suggested by previous case reports, small population-based studies, and noncomparative studies [8] [9] [10] [11] , mostly for pulmonary tuberculosis, but has not been clearly demonstrated. Previous works reported variable VTE prevalence in patients with active tuberculosis, always <1% [9, 20, 21] . In our study, the prevalence of VTE among patients with active tuberculosis was 2.07% (95% CI, 1.62%-2.59%).
It has been established that severe tuberculosis can be responsible for a transitory hypercoagulable state [22, 23] . Turken et al showed that patients with active pulmonary tuberculosis displayed thrombocytosis and increased fibrinogen, factor VIII, and plasminogen activator inhibitor 1 plasma levels, associated with depressed antithrombin III and protein C levels in the first month of treatment, resulting in activated coagulation and inhibited fibrinolysis [22] . All these modifications probably result from the inflammation cascade triggered by the chronic infection, as shown in several other acute infections [24] [25] [26] . Indeed, several experimental studies have shown that proinflammatory cytokines (interleukin 1, interleukin 6, tumor necrosis factor α) are produced during the acute phase of Mycobacterium tuberculosis infection, either by peripheral blood mononuclear cells [27] , or by lung, lymph node, and spleen macrophages interacting with mycobacterial products [28, 29] . These cytokines induce the production of various acute inflammation phase proteins and coagulation factors by hepatocytes, resulting in a hypercoagulable state [30, 31] . It has also been shown that, in vitro, M. tuberculosis induces the expression of a tissue factor in monocytes-macrophages, that is, a primary activator of the clotting cascade [32, 33] . Local factors may also induce the thrombosis of pulmonary arteries. Organ infection can trigger local thrombosis, as observed in Lemierre disease (tonsillar abscess complicated by jugular vein thrombosis and lung embolism), possibly due to endothelial cell alteration and adhesion molecule expression [34] . In addition, active tuberculosis may mechanically favor local blood stasis: venous compression by retroperitoneal lymph nodes may result in proximal thrombosis, as reported in patients with extrapulmonary tuberculosis [35] . Therefore, this raises the question as to whether thoracic venous compression by tuberculosis lymph nodes may similarly cause PE in pulmonary tuberculosis. The fact that some patients present with PE without associated DVT might support this hypothesis. However, we did not find any predominant link between a pulmonary localization of tuberculosis and VTE ( pulmonary tuberculosis and PE), or between the extrapulmonary forms of these 2 diseases (extrapulmonary tuberculosis and DVT). This suggests a predominant role of a systemic hypercoagulable state rather than local factors. Although the size of the population we studied confers statistical power to these results, they must be tempered by the fact that DVT may not have been always accurately coded in the database. Indeed, there were more instances of PE without DVT than of PE associated with DVT. This is physiologically improbable, and the likeliest explanation is that DVT is either not always accurately coded or not sought ( probably because DVT diagnosis may appear futile in cases with a diagnosis of PE). Consequently, we could not separate PE with DVT from PE without DVT, nor could we determine whether PE without DVT was more frequently associated with pulmonary tuberculosis, which would have suggested a role of local mechanisms in thrombus formation.
As expected, the classic VTE risk factors were associated with VTE, and the risk rose steadily as the number of risk factors increased. Surprisingly, heparin-based prophylaxis was found to be statistically significantly associated with VTE, probably reflecting an indication bias. Indeed, the more a patient is at risk of VTE, the more physicians prescribe thromboprophylaxis [36] . Supplementary Data 5 shows that the proportion of patients with preventive treatment increases with the number of risk factors.
As previously reported, we found that men were at higher risk of VTE than women [15, 16] and that black patients were, in multivariate analysis, at higher risk of PE than any other ethnic group [18, 19] . It is well known that blacks are more likely to suffer from tuberculosis [37] . The Centers for Disease Control and Prevention reported in 2013 that tuberculosis rates were 7.3 times higher in non-Hispanic blacks than in nonHispanic whites [38] . We found the prevalence of tuberculosis among black patients to be 0.03%, whereas it was 0.01% among white patients. Therefore, this population should be followed carefully as it is at higher risk for both tuberculosis and PE.
We found the prevalence of tuberculosis to be 0.01%, which is consistent with the literature. The fact that the database covered an entire year allowed us to avoid the problem of tuberculosis seasonality [39] . In communities with good sanitation, tuberculosis is a relatively rare disease, compared to cancer, heart failure, or other frequent risk factors, and it does not account for a large part of VTE diagnoses. Consequently, the presence of tuberculosis should not necessarily be sought in every case of VTE, but physicians should be aware of the risk of VTE in patients presenting with tuberculosis. However, we should stress that according to our study, mortality was much higher if patients presented with both tuberculosis and VTE than with one of these diseases alone (15% vs 2.7% and 2.5%, respectively; P < .001). Indeed, in univariate analysis and when adjusted for age, nutritional deficiency, and Charlson index, VTE was an independent prognostic factor among patients with tuberculosis. Therefore, patients with tuberculosis should be closely monitored for VTE. In terms of survival, there was no difference between pulmonary and extrapulmonary tuberculosis.
Our study has several limitations. The main limitation is the potential lack of information concerning the past and future medical history of the patients. Indeed, the strength of the Premier Perspective database relies on its mode of selection, which guarantees its representativeness of US healthcare. However, we have no certainty that the follow-up of a patient is complete, as subsequent hospitalization in another establishment not participating in the database, or occurring in the following year, is not reflected by the database. In the same way, the Premier Perspective database provides a code for each discharge of a patient, such that if a patient is hospitalized twice he or she will have 2 discharge codes. Therefore, if a patient receives the diagnoses of tuberculosis and of PE in separate hospital admissions, the 2 diagnoses will be considered as being unrelated.
Another limitation is the absence of chronology within a hospital stay. From the database, we could only detect different diagnoses but could not determine which one occurred first, or the length of time between the 2 diagnoses. However, we might consider that even if PE preceded the diagnosis of tuberculosis during the same stay, it is more likely that PE was secondary to active tuberculosis than the contrary. We should point out that the real significance of the values of ORs should be appreciated in comparison with the ORs of classic risk factors.
Moreover, our study relied upon ICD-9 codes. It is known that diagnosis coding at discharge has a high rate of disease misclassification, poor intra-and interobserver agreement, and poor predictive value, especially with tuberculosis [40, 41] , tempering our results. We had no certainty whether the cases of tuberculosis were latent or active; however, we assumed that the codes 010-018 and 647.3 describe active tuberculosis, as another specific code, "Past history of tuberculosis" (V12.01), exists and should include all inactive tuberculosis. However, despite possible misclassification and despite the high power of the study (due to a very large sample) that may tend to increase statistical significance of associations that might not be clinically significant, we believe that the association between tuberculosis and VTE is clinically relevant as the OR of tuberculosis is similar to the OR of classic and well-established risk factors. However, due to all the above-mentioned limitations, our results need to be confirmed by prospective clinical trials.
In conclusion, VTE has many risk factors, among which are acute infections. Active tuberculosis appears as another significant risk factor, comparable to the risk of VTE posed by cancer. We recommend that physicians should bear in mind the possibility of VTE when they follow patients with tuberculosis, and that they should include tuberculosis in their evaluation of thromboembolism risk.
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